Med Page Today
OCTOBER 22, 2024
(MedPage Today) -- Surgery schedules around the country may be washed out for several more weeks while a crucial IV and sterile fluids factory remains shut down for hurricane-related damage. People often plan non-emergency surgeries in the fall.
ECG Cases
OCTOBER 22, 2024
On this month's EM Quick Hits podcast: Kevin Wasko on post-tonsillectomy hemorrhage management, Brit Long on assessment and management of post-CABG surgical incision infections, Anand Swaminathan on evidence, pitfalls and tips on using Bougies, Leah Flannigan on when to suspect vascular injury in patients with low energy mechanism pelvic fractures, Andrew Petrosoniak on debriefing after cases: why, when and how.
American College of Cardiology
OCTOBER 22, 2024
Among patients with heart failure and reduced ejection fraction (HFrEF) started on sacubitril/valsartan, what is the association between asymptomatic versus symptomatic hypotension and clinical outcomes?
Dr. Smith's ECG Blog
OCTOBER 22, 2024
This was sent to me by a French colleague, Olivier Peyronie "Yesterday we received a 62 yo man with diabetes, hypertension and smoker. He reported typical chest pain since 4H AM and arrived at our ED at 10h with ongoing chest pain. The first ECG (10h14) showed TWI in inferior leads." Time zero: What do you think? Queen of Hearts Diagnosis: Not OMI with High Confidence (but in French!
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
HCPLive
OCTOBER 22, 2024
This overview highlights our upcoming conference coverage at the Fall Clinical Dermatology Conference in Las Vegas.
CardiacWire
OCTOBER 22, 2024
MedAxiom released its 12th annual Cardiovascular Provider Compensation and Production Report , providing an in-depth look at the current state of working in cardiology. The massive 60-page report (n=5,663 providers, 202 programs, 2023 data) outlined four notable employment trends… Rising PE Ownership – Nearly 50% of surveyed private practice groups were also part of a private equity portfolio, up from zero a few years ago.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
HCPLive
OCTOBER 22, 2024
Ustekinumab-aekn is set to enter the US market no later than February 21, 2025, as per a settlement and license agreement between Janssen, Teva, and Alvotech.
Med Page Today
OCTOBER 22, 2024
(MedPage Today) -- PHILADELPHIA -- Chest x-rays did not support the existence of an aspiration risk for surgical candidates using GLP-1 receptor agonists, according to a retrospective study. During the years when patients got the same anesthetic.
American College of Cardiology
OCTOBER 22, 2024
The goal of the DEFINE-FLAIR trial was to evaluate if functional lesion assessment by instantaneous wave-free ratio (iFR) would be noninferior to fractional flow reserve (FFR) among patients with stable angina or acute coronary syndromes.
Cardiovascular Diabetology
OCTOBER 22, 2024
Hypertension (HTN) and diabetes mellitus (DM) are two common comorbidities of heart failure with reduced ejection fraction (HFrEF), each of which can cause right ventricular (RV) dysfunction. The aim of this s.
American College of Cardiology
OCTOBER 22, 2024
Peripheral artery disease (PAD) represents a significant global health burden, affecting >200 million people and accounting for approximately 10-15% of the population >50 years of age.
Nature Reviews - Cardiology
OCTOBER 22, 2024
Nature Reviews Cardiology, Published online: 23 October 2024; doi:10.1038/s41569-024-01088-w In this Review, Schotten and colleagues summarize the latest knowledge on the molecular and cellular mechanisms of atrial fibrosis, describe the electrophysiological manifestations of atrial fibrosis, critically appraise the diagnostic tools to quantify atrial fibrosis, discuss emerging therapeutic interventions, and highlight knowledge gaps and future research directions.
American College of Cardiology
OCTOBER 22, 2024
In this interview, Drs. Anthony DeMaria and Scott Garrison review the BedMed and BedMed-Frail trials findings which proved the emphasis to patients is taking BP medication when they are least likely to forget, irrelevant of time of day.
Nature Reviews - Cardiology
OCTOBER 22, 2024
Nature Reviews Cardiology, Published online: 23 October 2024; doi:10.1038/s41569-024-01092-0 In this Tools of the Trade article, Bodagh and Williams highlight the utility of OpenEP, an open-source platform that offers standardized solutions for storage and analysis of electroanatomic mapping data.
American College of Cardiology
OCTOBER 22, 2024
The goal of the RELAX-AHF-2 trial was to assess the safety and efficacy of serelaxin compared with placebo in reducing cardiovascular (CV) mortality in patients presenting with acute heart failure.
Journal of Cardiothoracic Surgery
OCTOBER 22, 2024
This study was to analyze the roles of red blood cell distribution width (RDW), anion gap (AG) levels and their combined effects on the risk of acute kidney injury (AKI) following cardiac surgery.
HCPLive
OCTOBER 22, 2024
Masri previewed data to be presented at the AHA 2024 Scientific Sessions and shared his excitement for the ongoing phase 3 trial of NTLA-2001.
CTVS
OCTOBER 22, 2024
Did you know that one in four adults will suffer a stroke at some point in their life? A stroke occurs when the carotid arteries, the two main arteries that supply blood to the brain, become narrowed and restrict its flow. This often results from plaque build-up within the arteries known as carotid disease.
HCPLive
OCTOBER 22, 2024
A new study revealed patients with genetic variation of hCAZyme enzymes were more likely to reach success with low-carb diets to relieve IBS symptoms than those without.
JAMA Cardiology
OCTOBER 22, 2024
Hypertension is the leading modifiable risk factor for cardiovascular disease (CVD) in the US, affects 122 million adults, and is projected to exceed 180 million adults by 2050. Yet, control of blood pressure (BP) remains dismal with less than half of adults achieving control with disproportionately lower rates among non-Hispanic Black adults compared with non-Hispanic White adults.
HCPLive
OCTOBER 22, 2024
Brain-gut behavioral treatments, such as CBT and hypnotherapy, may alleviate abdominal pain in IBS, though no single therapy proves superior to others.
JAMA Cardiology
OCTOBER 22, 2024
This genetic association study uses data from Black participants in the the Genetics of Hypertension Associated Treatments (GenHAT) study to investigate the ability of systolic blood pressure polygenic risk scores to predict antihypertensive treatment response and apparent treatment-resistant hypertension.
HCPLive
OCTOBER 22, 2024
This analysis reconfirms the efficacy of dupilumab using a single-center design, a large sample size, and patients with chronic hand eczema.
European Journal of Heart Failure
OCTOBER 22, 2024
Fine particulate matter (PM 2.5 ) constituents and incident heart failure. AP, attributable proportion due to interaction; CI, confidence interval; EC, elemental carbon; HR, hazard ratio; OM, organic matter; PRS, polygenic risk score; NH 4 + , ammonium; NO 3 , nitrate; RERI, relative excess risk due to interaction; SO 4 2 , sulfate. Aims Long-term fine particulate matter (PM 2.5 ) exposure has been linked to incident heart failure (HF), but the impacts of its constituents remain unknown.
HCPLive
OCTOBER 22, 2024
Test your knowledge of the 2024 American College of Gastroenterology focal liver lesion diagnosis and management guidelines with this clinical quiz!
European Journal of Heart Failure
OCTOBER 22, 2024
Prognostic impact of visit-to-visit changes in heart rate (HR) among patients with heart failure (HF) in the PARADIGM-HF and PARAGON-HF trials. AF, atrial fibrillation; CI, confidence interval; CV, cardiovascular; FU, follow-up; HFH, heart failure hospitalization; ICD, implantable cardioverter-defibrillator; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; PPM, permanent pacemaker; RCT, randomized controlled trial.
HeartRhythm
OCTOBER 22, 2024
Pulsed field ablation (PFA) is a novel method of cardiac ablation in which electrical fields are used to create microscopic pores in the cardiomyocyte cell membrane resulting in cell death. Unlike traditional thermal radiofrequency and cryoablation technologies, PFA is cardiomyocyte preferential, reducing the risk of collateral damage to the esophagus and phrenic nerve.
Journal of the American Heart Association
OCTOBER 22, 2024
Journal of the American Heart Association, Ahead of Print.
HeartRhythm
OCTOBER 22, 2024
Ablation of infrequent premature ventricular complexes (PVC) is challenging.
Journal of the American Heart Association
OCTOBER 22, 2024
Journal of the American Heart Association, Ahead of Print.
Circulation: Arrhythmia and Electrophysiology
OCTOBER 22, 2024
Circulation: Arrhythmia and Electrophysiology, Ahead of Print.
European Journal of Heart Failure
OCTOBER 22, 2024
Aims To estimate the global burden of myocarditis in the general population from 1990 to 2021. Methods and results Data on myocarditis were retrieved from the Global Burden of Disease Study 2021. Incidence, deaths, and disability-adjusted life years (DALYs), along with their age-standardized rates (ASRs) per 100 000 population, were used to measure the burden of myocarditis.
Expert insights. Personalized for you.
111 
Let's personalize your content